MétaCan
← tous les travaux

Mechanisms involved in cAMP mediated inhibition of the Ubiquitin‐Proteasome system

Pourquoi ce travail est-il dans la base ?

Une base qui oublie comment elle a trouvé un travail ne peut pas être vérifiée. Voici les voies qui ont admis celui-ci.

Affiliation canadienneUne personne signataire a déclaré un établissement canadien. C'est la seule voie dont dispose la base habituelle.

Le tri à trois modèles

les 1 000 travaux triés →

Les trois modèles l'ont jugé hors champ.

strate : aff_core · poids de sondage : 5595.24 (l'échantillon est stratifié ; tout taux calculé sans le poids est faux)
Claude Opus 4.8OUT
genre : empirical
porte sur le Canada: non
confiance: high

Physiology study of cAMP-mediated inhibition of the ubiquitin-proteasome system in rat skeletal muscle.

GPT-5.6 (high)OUT
genre : empirical
porte sur le Canada: non
confiance: high

It studies cellular signaling and proteolysis in rat muscle, not research methods or the research system.

Grok 4.5OUT
genre : empirical
porte sur le Canada: non
confiance: high

Domain muscle physiology and UPS regulation in rats, not a study of research practice.

Résumé

Aim: This study was undertaken to investigate the role of beta‐2 adrenoceptors and cAMP in regulating the Ubiquitin‐proteasome system (UPS) in skeletal muscle from normal rats. Methods and results: The activity of UPS and the Akt/FoxO signaling pathway were measured in skeletal muscle from rats treated with clenbuterol (3 mg/kg wt; sc), a selective beta‐2 adrenergic agonist, for 3 days. In extensor digital longus (EDL) muscle, clenbuterol increased by 30% muscle weight, reduced by 45% the UPS activity and increased by 30% the phosphorylation of Akt and FoxO3. The addition of isobutylmethylxanthine (IBMX; 10 −3 M), a cAMP phosphodiesterase inhibitor, to the incubation medium increased cAMP levels (4‐fold) and decreased by 50% the UPS activity in isolated soleus and EDL muscles from normal rats. IBMX in vitro also reduced the levels of ubiquitin‐protein conjugated and the mRNA levels of the atrogin‐1/MAF bx (50%) and the E 2 ‐14KDa ubiquitin conjugating enzyme (30%) transcripts in muscles from normal rats. Ubiquitin and MuRF1 mRNA were not altered by IBMX in vitro. Conclusions: These data suggest that stimulation of beta‐2 adrenoceptors, through the activation of cAMP and Akt signaling pathways, inhibit ubiquitin‐proteasome proteolysis by increasing FoxO3 phosphorylation and suppressing atrogin‐1 mRNA expression in skeletal muscle from normal rats. Financial support: CNPq, CAPES, FAPESP

Conservé avec la notice de tri, où il sert de preuve aux étiquettes ci-dessus.

La notice

Revue
The FASEB Journal
Thématique
Pharmacological Effects and Assays
Domaine
Agricultural and Biological Sciences
Établissements canadiens
McGill University
Organismes subventionnaires
Conselho Nacional de Desenvolvimento Científico e TecnológicoCoordenação de Aperfeiçoamento de Pessoal de Nível SuperiorFundação de Amparo à Pesquisa do Estado de São Paulo
Mots-clés
IBMXClenbuterolUbiquitinInternal medicineEndocrinologyProtein kinase BProteasomeChemistrySkeletal musclePhosphorylationFOXO3MyocyteStimulationBiologyBiochemistryMedicineForskolin
Résumé présent dans OpenAlex
oui